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Methods: From January 1980 to December 1993, 52 patients underwent 
surgical resection for tumors involving the sternum. The series included 20 
primary malignant tumors, 4 desmoid tumors, 2 malignant umors infil- 
trating the sternum from adjacent organs, 19 local recurrences or metas- 
tases of breast umors, and 7 metastases ofother tumors. Total sternectomy 
was performed in 5 patients, subtotal sternal resection in 19, and partial 
resection (less than 50% of the sternum) in 28. Concurrent en bloc resection 
included anterior ibs in 37 patients, clavicle in 11, lung in 12 patients, 
pericardium in 7, and diaphragm in 2. The chest was reconstructed with 
prosthetic material and a myocutaneous flap in 26 patients (50%), pros- 
thetic material only in 12 patients (23%), a myocutaneous flap in 5 patients 
(10%), and other techniques in the remaining patients. In 47 patients (90%) 
the resection was radical, and in the remaining 5 patients it was palliative. 
Results: No perioperative deaths occurred. After a median follow-up of 39 
months, the overall 3-year survival was 58% and the S-year survival 46%, 
with a median survival of 50 months. In 24 patients with primary tumor the 
S-year survival after radical resection was 63%, and in 23 patients with 
secondary invasion (direct extension or metastasis) the S-year survival was 
38% (median 35 months). In recurrent breast cancer the S-year survival 
was 48% in patients with direct extension to the chest wall and 60% in 
patients with distant bone metastasis. Conclusions: Our experience demon- 
strates that sternal resection is a safe and effective treatment, which may 
improve the patient's quality of life and achieve a long-term survival not 
only in primary tumors but also in selected secondary malignant tumors of 
the sternum. (J Thorac Cardiovasc Surg 1997;114:93-9) 
T umors of the sternum have been considered achallenging problem for a long time. Stability and 
reconstruction of chest wall defects have caused the 
main difficulties in radical full-thickness resections. 
Improvement of surgical techniques, especially by 
means of myocutaneous flaps and prosthetic mate- 
rials, has resulted in successful sternectomies and 
simultaneous reconstructions. 
The development of safe techniques for chest wall 
reconstruction has expanded the role of surgery in 
this field. Extensive chest wall resections, including 
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total sternectomy, can now be performed with vir- 
tually no operative mortality) A methyl methacry- 
late composite prosthesis within two layers of 
polypropylene mesh (Marlex mesh, Bard Implants, 
Billerica, Mass.) offers the best mechanical strength 
and external profile after total or subtotal sternec- 
tomy. 
Surgical treatment should be considered the best 
option in the majority of patients with primary 
malignant umors involving the sternum, 2-s and it 
can achieve a definitive cure. In high-grade sarco- 
mas, induction chemotherapy or postoperative che- 
motherapy/radiotherapy (or both) may be necessary 
to consolidate the results of surgical treatment. 6 
Wide surgical resection with adequate margins is no 
longer limited by the size of the chest wall defect, 
because concurrent reconstruction with prosthetic 
materials with or without myocutaneous flaps is a 
feasible treatment in most departments of thoracic 
surgery. 
The role of surgical treatment is still the subject of 
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Table I. Patients'features 
Total 
Primary Breast Metastasis* No. % 
Age (yr) 
0-29 3 0 2 5 9 
30-59 17 9 5 31 60 
>60 4 10 2 16 31 
Sex 
Male 14 0 7 21 40 
Female 10 19 2 31 60 
Total 24 19 9 52 100 
*Including two cases of direct extension from adjacent tumors. 
controversy for secondary malignant umors of the 
sternum, and particularly for recurrence or metas- 
tasis of breast cancer. 7 In recurrent breast cancer, 
surgery has usually been performed for palliation 
after failure of radiation, but recently an increase in 
survival has been reported after resection, a'9 On the 
other hand, sternal resection of metastases from 
other distant umors is occasionally performed with 
a purely palliative intent. 
This article reports our experience with sternal 
resections for primary or secondary tumors. 
Materials and methods 
Between January 1980 and December 1993, at the 
Division of Thoracic Surgery of the Istituto Nazionale 
Tumori, 52 consecutive patients underwent sternal resec- 
tion for tumors involving the sternum, costochondral 
cartilages, anterior ribs, parasternal soft tissues, or a 
combination of these structures (Table I). 
Primary malignant tumors comprised the main group, 
encompassing 20cases (39%); in addition, there were 4 
(8%) desmoid tumors, 2 (4%) tumors infiltrating the 
sternum from adjacent organs, 19 (37%) recurrences or 
metastases from breast cancer, and 7 (14%) metastases 
from other tumors. Twenty-one patients were male (mean 
age 48 years, range 16 to 75 years) and 31 were female 
(mean age 53 years, range 23 to 77 years). 
Of the 20 primary malignant tumors (Table II), 19 were 
sarcomas (the main types being chondrosarcoma in 7 and 
osteosarcoma in 3) and 1 was a non-Hodgkin's lymphoma 
of the sternum. Two patients with primary malignant 
tumors had radiation-induced sarcomas of the sternum 
occurring 13 and 14 years after high-dose mediastinal 
irradiation (76 and 126 Gy, respectively) for Hodgkin 
disease. Fig. i illustrates 2 of the cases of primary sarcoma 
of the sternum. 
Four patients with desmoid tumors were included in 
this series because their surgical management was similar 
to that of patients with malignant tumors; however, they 
were analyzed separately in the survival curves. One 
patient had lung cancer involving the anterior ibs and 
costochondral cartilages, and another had laryngeal can- 
cer involving the upper part of manubrium. 
Nineteen patients had locoregional recurrence of breast 
Table II. Primary tumors 
Malignant 20 
Sarcoma 19 
Chondrosarcoma 7 
Osteosarcoma 3 
Askin's tumor (PNET) 2 
Liposarcoma 1 
Leiomyosarcoma 1 
Rhabdomyosarcoma 1 
Angiosarcoma 1 
Soft tissue sarcoma (N.O.S.) 3 
NH lymphoma 1 
Desmoid 4 
PNET, Peripheral neuroepithelioma; N.O.S., not otherwise specified; NH, 
non-Hodgkin's. 
cancer: relapse was in the soft tissues of the parasternal 
area or at the level of the internal thoracic lymph nodes in 
14 patients, and a solitary metastasis within the sternum 
occurred in 5 patients. Seven patients underwent surgical 
treatment for sternal metastases of various tumors, includ- 
ing 2 synovial sarcomas, 2 thyroid cancers, 2 lung cancers, 
and 1 gastric ancer. Thirty-nine (75%) patients had chest 
pain. Seventeen patients had received preoperative radio- 
therapy and 12 had had preoperative chemotherapy for 
the chest wall lesion. 
The diagnosis and surgical management were based on 
the history of the disease, clinical findings of a mass or 
pain (or both), and computed tomographic or magnetic 
resonance imaging (or both). In a few cases in which 
clinical and radiologic findings clearly indicated the pres- 
ence of a primary malignant tumor of the sternum, we 
have performed radical en bloc resection without prior 
biopsy. Possible invasion of lung, pericardium, diaphragm, 
or clavicle was assessed by computed tomography or 
magnetic resonance imaging. 
Follow-up was updated in July 1995, after a minimum 
observation of 18 months. The actuarial survival from the 
time of sternal resection was calculated with life table 
analysis according to the method of Kaplan and Meier, 
and statistical nalysis was performed by the log-rank test. 
Results 
Resection and reconstruction. Complete resec- 
tion of the sternum was performed in 5 patients 
(10%), subtotal resection encompassing more than 
50% of the sternum in 19 patients (37%), and 
partial resection including less than 50% of the 
sternum in 28 patients (54%) (Table III). 
En bloc resection including the anterior segment 
of ribs was carried out in 37 patients (71%); more 
than five ribs were resected in 2 patients, three or 
four in 18, and one or two in 17 patients; resection 
was limited to the costal cartilages in the remaining 
patients (Table III). The average defect created by 
resection of the sternum (and ribs) was 10 x 7.5 cm, 
and the largest defect was 27 × 12 cm. Concurrent 
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Fig. 1. Axial and sagittal views of two primary tumors of the sternum: Askin-Rosai (A and B) and 
osteosarcoma (C and D). 
Table I IL  Extent of  resection Table IV. Modality of  reconstruction 
Total Total 
Primary Breast Metastasis No. % Primary Breast Metastasis No. % 
Sternum Bone 
Total 5 0 0 5 9 Marlex mesh 11 14 4 30 59 
Subtotal (>50%) 10 7 2 19 37 Marlex composite* 7 0 1 8 11
Partial (<50%) 11 12 5 28 54 Other materials 5 2 0 7 7 
Ribs None 2 3 2 7 12 
0 8 5 2 15 29 Soft tissues 
1-2 5 7 5 17 33 Latissimus dorsi muscle 7 3 0 10 20 
>3 13 7 0 20 38 
Associated resections Major pectoralis muscle 9 4 3 6 29 
Rectus abdominis muscle 1 3 1 5 9 Lung 5 6 1 12 23 
Pericardium 6 1 0 7 13 Skin flaps 9 9 3 21 34 
Clavicle 6 2 3 11 21 *Six acrylic and two silicone. 
Diaphragm 2 0 0 2 4 
resect ion of the lung was done in 9 patients, clavicle 
in 11 patients, per icard ium in 3, d iaphragm in 1, 
clavicle, lung, and per icard ium in 3, and d iaphragm 
and per icard ium in 1 (Table I I I) .  
Var ious types of reconstruct ion were appl ied (Ta- 
ble IV), depending on the individual surgeon's 
choice: Mar lex mesh was the prosthet ic mater ia l  
used most often (38 patients, 73%); myocutaneous 
flaps were used in 31 patients (60%); in 26 patients 
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Fig. 2. Actuarial survival after radical resection accord- 
ing to the type of sternal involvement: primary tumor (n = 
24) versus econdary invasion (direct extension or metas- 
tasis, n = 23). 
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Fig. 3. Survival after radical resection for primary tumor, 
according to the histologic type: desmoid (n = 4), low- 
grade sarcomas (n = 11), and high-grade sarcomas (n = 
9). 
prosthetic materials were used in conjunction with 
myocutaneous flaps (50%); and in 5 patients flaps 
were used alone (10%). 
The intent of the operation was curative in 47 
patients (90%), and in 5 it was palliative because of 
diseased surgical margins (3 patients) or concur- 
rent presence of distant metastases in other or- 
gans (2 patients). In such patients we decided to 
operate to obtain local control of the mass, reduce 
the thoracic pain, and improve the quality of life. 
All 5 patients were in good general condition and 
were not suitable for palliative radiotherapy for 
various reasons. 
Postoperative course. No perioperative deaths 
occurred. Fourteen patients (27% _+ 6%) were 
affected by minimal morbidity. Local complica- 
tions occurred in 8 patients (15%). In 3 patients (1 
of whom had diabetes) the wound was necrotic: 
this necrosis was limited and healed spontane- 
ously in 1 patient, but in the other 2 patients 
excision was necessary and a myocutaneous flap 
was used (in the first patient a major pectoralis 
flap and in the second one a latissimus dorsi flap, 
after the previous rectus abdominis flap had been 
removed). One patient had a superficial infection 
and four had a seroma treated with medical 
therapy. One patient had a local sepsis that 
necessitated removal of the silicone prosthesis 
and repeated local irrigation. It was not necessary, 
however, to remove the Marlex mesh. Systemic 
morbidity occurred in 8 patients and consisted of 
significant pyrexia necessitating treatment with 
antibiotics (in 1 patient, bilateral pneumonia). 
On average, the chest drains were removed 9days 
after the operation (range 2 to 28 days), and after 7 
days in uncomplicated cases. Average postoperative 
hospital stay was 14 days (range 3 to 60 days); if 
complicated cases are excluded, the average stay was 
9 days. For prolonged loss of proteins many patients 
required plasma or albumin (or both); 21 patients 
had blood transfusion, on average 3units per patient 
(range 1 to 7 units). Electrolyte alterations were 
infrequent and never severe. 
Only 12 patients received postoperative adjuvant 
treatment consisting of chemotherapy (5 patients) 
or radiotherapy (7 patients). 
Survival. After a median follow-up of 39 months, 
the overall 3-year survival was 58% and the 5-year 
survival 46%, with a median value of 50 months and 
a death rate per person-year (DR) of 0.14. Among 
the patients who underwent radical operations, 27 
(53%) were alive (median survival 67 months) and 
24 (47%) were free of disease (DR = 0.12). None of 
the five patients undergoing palliative resection 
survived 5 years, and the median survival was only 
11 months (DR = 0.57). 
Fig. 2 illustrates the actuarial survival after radical 
resection according to the type of sternal involve- 
ment. In 24 cases of primary tumor the 5-year 
survival was 63% (median not reached) and in 23 
cases of secondary invasion (direct extension or 
metastasis) the 5-year survival was 38%, with a 
median value of 35 months (DR = 0.07 and 0.18, 
respectively). 
Fig. 3 illustrates the survival of patients with 
primary tumors according to the histologic diagno- 
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sis. All 4 patients with desmoid tumors were alive 
and free of disease at 5 years, whereas the 5-year 
survival was 60% for the 11 patients with low-grade 
sarcoma nd 30% (median 17 months) for the 9 
patients with high-grade sarcoma (DR = 0.08 and 
0.27, respectively). 
In patients who underwent sternal resection for 
recurrent breast cancer (Fig. 4), the 5-year survival 
was similar regardless of whether the patient had 
direct extension to the chest wall or distant bone 
metastasis (48% vs 60%; DR = 0.15 and 0.13, 
respectively), with a remarkably long median sur- 
vival. However, none of the 5 patients with meta- 
static tumors other than breast cancer survived, and 
the median survival was only 12 months (not 
shown). 
Regarding symptomatic benefit, none of the pa- 
tients operated on for advanced breast cancer had 
local tumor relapse or recurrence of symptoms, 
namely chest pain, during the follow-up period. 
Discussion 
Resection of large portions of the chest wall has 
been a complex problem in the past on account of 
technical intraoperative difficulties, surgical compli- 
cations, and respiratory failure caused by the chest 
wall instability and paradoxic respiratory move- 
ments. Present-day cooperation between thoracic 
and plastic surgeons allows more aggressive resec- 
tions, 2 and neither the size nor the position of the 
chest wall defect limits surgical management, be- 
cause resection and reconstruction are performed in 
a single operation that provides immediate chest 
wall stability. 
Surgery is the treatment of choice for patients 
with primary tumors of the chest wall including the 
sternum.i, 10 For some authors, survival is not sig- 
nificantly different between primary and recurrent 
sarcomas. 4 
For primary malignant tumors of the chest wall, a 
5-year survival range of 46% 5 to 66% 11 has been 
reported, with a wide difference between high-grade 
and low-grade sarcomas. Five-year survival ranges 
from 16.6% for peripheral neuroepitheliomas to 
89% for chondrosarcomasJ 2 Others report that 
5-year survival was 14% in osteosarcomas and 80% 
in chondrosarcomas. 6 
After a median follow-up of 31.5 months, the 
survival was 79% for primary tumors and 33% for 
metastatic tumors2; in another series, survival was 
59% without any difference among primary and 
recurrent umors. 4 Our series confirms that low- 
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Fig. 4. Survival after radical resection for recurrent 
breast cancer: direct chest wall extension (  = 7) versus 
distant bone metastasis (n = 11). 
grade primary sarcomas have a better prognosis 
than high-grade tumors (60% vs 30% at 5 years; see 
Fig. 3), although because of the limited number of 
observations the difference does not reach statistical 
significance. 
Desmoid tumors are considered to be a benign 
fibromatosis or a low-grade fibrosarcoma by pathol- 
ogists, but they should be resected with wide mar- 
gins in normal tissue, as are primary malignant 
tumors, to avoid recurrence, a 
Sarcomas arising in the sternum after extensive 
mediastinal irradiation for lymphomas may be diffi- 
cult to treat. In fact, the limits between the tumor 
and radiation-induced fibrosis may not be properly 
defined, and the tumor is likely to recur despite 
undiseased resection margins at pathologic exami- 
nation. In this series, the 2 patients with sarcomas of 
the sternum induced by mediastinal irradiation for 
Hodgkin's disease had widespread mediastinal re- 
currence afew months after adical sternectomy and 
died within 2 years of the operation. 
On the other hand, the role of surgery remains a
subject of controversy for recurrence and metastasis 
of breast cancer involving the chest wall and ster- 
num,S, 13 in which surgery may be considered for 
simple palliation and local control of the disease. 
The actuarial 5-year survival after resection for 
breast cancer recurrences ranges from 34% 14 to 
63% 15 in the literature. A few authors have advo- 
cated a radical surgical approach for patients with 
solitary breast cancer ecurrence or metastasis n- 
volving the chest wall and sternum, because survival 
may be improved. 7'9 It has been suggested that 
sternal metastases may remain solitary for a long 
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time and that their evolution may be different from 
that of vertebral metastases, possibly because of the 
lack of communication with paravertebral venous 
plexus through which cancer cells spread to other 
bones, s In our opinion, surgical therapy should be 
considered occasionally for isolated bone metastases 
of breast cancer as part of a combined multimodality 
approach that includes radiotherapy, chemotherapy, 
and hormone therapy. Adjuvant chemotherapy and 
hormone therapy increase the disease-free survival 
and overall survival. 16 
The prognosis of local chest wall recurrence or 
metastasis of breast cancer is better in the absence 
of internal thoracic and mediastinal lymph node 
metastases; if mediastinal lymph nodes are involved, 
the chance of progression with metastatic dissemi- 
nation is much higher. 8Surgery may still be consid- 
ered in such cases, whenever adequate local control 
cannot be achieved by radiotherapy or chemother- 
apy, to palliate thoracic pain, inflammation, infec- 
tions, and bleeding associated with the recurrence. 
In the present series, the 5-year survival was equally 
good in patients with direct extension to the chest 
wall or distant bone metastasis (48% vs 60%, see 
Fig. 4). 
Regarding the margin of resection, most au- 
thors recommend that the incision be placed 2 to 
4 cm from the margin of the tumor or the irradiated 
tissue. 7Others 2advocate that a minimum of 4 cm 
of normal tissue be removed en bloc with full- 
thickness resection of the involved bone (manu- 
brium, sternal body, or whole sternum) and cor- 
responding anterior tract of the ribs bilaterally, 
one uninvolved rib and the intercostal space 
above and below. 4
Many materials had been used in the past for 
reconstruction f anterior defects of the chest wall: 
fascia lata, 17 rib grafts, 18 large cutaneous flaps, and 
contralateral breast. 19 A great advance was made 
when the use of a latissimus dorsi flap with preser- 
vation of the vascular thoracodorsal system was 
introduced.3, 2o The strategy for reconstruction now 
has to be based on the extent of skeletal and soft 
tissue defect. The potential combinations of pros- 
thetic materials and myocutaneous flaps are count- 
less, and often more than one option can effectively 
deal with the individual patient's problem. The need 
for skeletal reconstruction depends on the size and 
site of resection2: reconstruction is necessary for the 
sternum and for the anterior and lateral tracts of the 
ribs, whereas posterior defects may not require 
reconstruction if they are fully covered by the scap- 
ula without any risk of inward rotation 5 or if they 
can be stabilized by adjacent muscles. For some 
authors sternal and posterior defects require less 
stabilization than anterior and lateral defects. 2' 21 
Various options of prosthetic materials are possible. 
Marlex mesh, polytetrafluoroethylene patch,* and 
Prolene mesh (Ethicon, Inc., Somerville, N.J.) are 
well tolerated, easy to handle, and must be sutured 
under tension, which improves the stability of the 
chest wall. 3' 4 Polytetrafluoroethylene has the advan- 
tage of being impervious to the flow of air and 
fluids. 22 Neither Marlex, Vicryl (Ethicon), nor Pro- 
lene mesh has this characteristic, but in our experi- 
ence a transient flow of serum or blood through the 
prosthesis did not create any problem. Among the 
various prosthetic meshes with similar physical 
properties, Marlex mesh remains the most widely 
used because of its solidity, manageability, and 
long-term tolerability, the virtual absence of foreign 
body reactions or septic complications, and the low 
cost. After total sternectomy or large resections 
involving the lateral aspect of the chest wall and 
more than four ribs, the Marlex mesh-methacrylate 
composite offers the best results in terms of fixation, 
protection of endothoracic organs, and lung expan- 
sion.6, 23 The mesh-methacrylate composite is man- 
ufactured at the time of the operation, when the size 
and shape of the prosthesis can be determined, and 
provides excellent functional and cosmetic results. 
Paradoxic movement of the chest can be prevented 
with this prosthesis, even with large defects. None- 
theless, in our experience, when a partial sternal 
resection is performed with preservation of the 
anterior chest wall continuity (manubrium or a part 
of the sternal body with adjacent ribs), it is possible 
to use the simple Marlex mesh fixed under tension 
to obtain adequate skeletal stability. 
For the reconstruction f soft tissue defects, myo- 
cutaneous flaps have replaced other tissues, such as 
simple skin flaps or breast ransposition, because of 
their safety and long-term reliability. This aspect is 
particularly critical in managing breast cancer ecur- 
rence because of the damage caused by the previous 
operation and radiation to the surrounding tissues. 
Depending on the specific circumstances, different 
myocutaneous flaps can be used, alone or in combi- 
nation: major pectoralis muscle to repair upper 
anterior defects, transverse rectus or serratus mus- 
cle for anterior and lateral defects, and latissimus 
*Gore-Tex patch, registered trade name of W. L. Gore & 
Associates, Inc., Elkton, Md. 
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dorsi muscle for any anterior or lateral defects. The 
omentum has been proposed as a valid alternative to
muscular flaps for its excellent b lood  supply 24 and 
good performance in potentially infected areas. 
Clinical results are favorable, 25 but the obvious 
disadvantages are the need for additional laparot- 
omy and alternative sources of skin cover. 
In conclusion, our results confirm that even ex- 
tensive resection of the sternum for primary or 
secondary tumors followed by reconstruction with 
prosthetic material or a myocutaneous flap is a safe 
and effective treatment. Various combinations of 
myocutaneous flaps and prosthetic materials can be 
used, and the choice of technique depends on size, 
position of the defect, and surgeon's preference. It is 
clear, however, that major esections of the sternum, 
en bloc with pericardium, lung, or diaphragm, can 
be performed with no mortality, minimum morbid- 
ity, and reasonable duration of the hospital stay. In 
primary tumors, as demonstrated by a recent series, 6
radical resection may provide a permanent eradica- 
tion of the disease and a good prospect for long- 
term survival. Moreover, in patients with recurrent 
breast cancer, sternal resection offers not only a 
significant and permanent palliation but also a pro- 
longed survival. 
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